Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Ionis Pharmaceuticals Inc | 1,105 |
| 2 | Procter and Gamble Co | 510 |
| 3 | Purdue Pharma LP | 499 |
| 4 | Syngenta Participations AG | 368 |
| 5 | Boehringer Ingelheim International GmbH | 290 |
| 6 | Merck Sharp & Dohme LLC | 276 |
| 7 | Bayer Pharma AG | 263 |
| 8 | Boehringer Ingelheim Animal Health USA Inc | 251 |
| 9 | Abbott Cardiovascular Systems Inc | 243 |
| 10 | Kenvue Brands LLC | 242 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 16,603 |
| 2 | A61K | Medicinal preparations | 16,406 |
| 3 | C07D | Heterocyclic compounds | 7,084 |
| 4 | C12N | Microorganisms, enzymes | 3,389 |
| 5 | C07K | Peptides | 3,208 |
| 6 | C07C | Acyclic and carbocyclic compounds | 1,563 |
| 7 | A61L | Sterilising / disinfecting materials | 1,337 |
| 8 | Y02A | Climate change adaptation | 1,280 |
| 9 | A61Q | Cosmetics, personal care | 1,212 |
| 10 | G01N | Investigating / analysing materials | 1,146 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives | 2003 | Pfizer Corp SRL | 42 |
| Use of carprofen and derivatives therof for treating or preventing articular degeneration | 2000 | Pfizer Products Inc | 5 |
| A kind of method that use biological enzyme stereoselectivity splits Carprofen enantiomer | 2017 | HUNAN TECHNOLOGY COLLEGE | 3 |
| Synthesis of carprofen | 2009 | SHANDONG FANGXING SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. | 3 |
| STABLE CARPROFEN COMPOSITION | 2004 | Jurox Pty Ltd | 3 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Inflammatory mediators and NSAID effects | 12 |
| 2 | Veterinary Pharmacology and Anesthesia | 6 |
| 3 | Animal Behavior and Welfare Studies | 1 |
| 4 | Animal Nutrition and Physiology | 1 |
| 5 | Biosimilars and Bioanalytical Methods | 1 |
| 6 | Bone health and treatments | 1 |
| 7 | Cancer, Stress, Anesthesia, and Immune Response | 1 |
| 8 | Helicobacter pylori-related gastroenterology studies | 1 |
| 9 | Meat and Animal Product Quality | 1 |
| 10 | Microfluidic and Capillary Electrophoresis Applications | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | A. E. WatermanâPearson | University of Bristol | 9 |
| 2 | J. V. Roughan | Newcastle University | 7 |
| 3 | P. Lees | Royal Veterinary College | 7 |
| 4 | A. Nolan | University of Glasgow | 6 |
| 5 | B. Ludwig | Roche (Switzerland) | 6 |
| 6 | Anton Simeonov | National Center for Advancing Translational Sciences | 5 |
| 7 | Ajit Jadhav | National Center for Advancing Translational Sciences | 4 |
| 8 | B. Duncan X. Lascelles | University of Bristol | 4 |
| 9 | Caroline Lee | Commonwealth Scientific and Industrial Research Organisation | 4 |
| 10 | Dorothy Cimino Brown | University of Pennsylvania | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Development of a scale to evaluate postoperative pain in dogs | 1999 | 379 | Veterinary Pharmacology and Anesthesia |
| Selfâselection of the analgesic drug carprofen by lame broiler chickens | 2000 | 354 | Coccidia and coccidiosis research |
| Ability of the Canine Brief Pain Inventory to detect response to treatment in dogs with osteoarthritis | 2008 | 352 | Pain Mechanisms and Treatments |
| Effect of carprofen on lameness in broiler chickens | 1999 | 245 | Animal Nutrition and Physiology |
| Efficacy and Kinetics of Carprofen, Administered Preoperatively or Postoperatively, for the Prevention of Pain in Dogs Undergoing Ovariohysterectomy | 1998 | 239 | Anesthesia and Pain Management |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular structure and formula of carprofen?
What are the common commercial and brand names for carprofen?
What are the primary research topics associated with carprofen in published literature?
What patent applications cover carprofen's medical uses?
How has research and patent activity for carprofen trended in recent years?